Mammary Cell News Volume 15.01 | Jan 12 2023

    0
    68








    2023-11-12 | MCN 15.01


    Mammary Cell News by STEMCELL Technologies
    Vol. 15.01 – 12 January, 2023
    TOP STORY

    MLL3 Loss Drives Metastasis by Promoting a Hybrid Epithelial–Mesenchymal Transition State

    Researchers showed that deletion of the epigenetic regulator MLL3, a tumor suppressor frequently altered in human cancer, promoted the acquisition of hybrid epithelial–mesenchymal transition in breast cancer cells.
    [Nature Cell Biology]

    Abstract
    Facts Vs. claims. Three scientists peer reviewed a life science vendor to get to the truth. See for yourself.
    PUBLICATIONSRanked by the impact factor of the journal

    Targeting ATAD3A-PINK1-Mitophagy Axis Overcomes Chemoimmunotherapy Resistance by Redirecting PD-L1 to Mitochondria

    Scientists discovered that therapeutic response to immune checkpoint inhibitor plus paclitaxel was associated with subcellular redistribution of PD-L1.
    [Cell Research]

    Full Article

    Annexin A1 Is a Polarity Cue That Directs Mitotic Spindle Orientation during Mammalian Epithelial Morphogenesis

    The authors identified the membrane-associated protein Annexin A1 as an interactor of leucine-glycine-asparagine repeat protein in mammary epithelial cells.
    [Nature Communications]

    Full Article

    CD26-Negative and CD26-Positive Tissue-Resident Fibroblasts Contribute to Functionally Distinct CAF Subpopulations in Breast Cancer

    Through various transplantation studies in mice, investigators showed that cancer-associated fibroblasts (CAFs) in both invasive lobular breast cancer and TNBC originated from mammary tissue-resident normal fibroblasts.
    [Nature Communications]

    Full Article

    ZBTB18 Restricts Chromatin Accessibility and Prevents Transcriptional Adaptations That Drive Metastasis

    Scientists reported an epigenetic pliancy mechanism that allowed cancer cells to successfully metastasize.
    [Science Advances]

    Full Article

    Proteolytic Regulation of CD73 by TRIM21 Orchestrates Tumor Immunogenicity

    Researchers reported that the elevation of CD73 levels due to its aberrant turnover was correlated with poor prognosis in immune-cold TNBCs.
    [Science Advances]

    Full Article

    A Cdh3-β-Catenin-Laminin Signaling Axis in a Subset of Breast Tumor Leader Cells Control Leader Cell Polarization and Directional Collective Migration

    The authors developed 3D computational models, which hypothesized that leader cells needed to generate high protrusive forces and overcome extracellular matrix resistance at the leading edge.
    [Developmental Cell]

    Full ArticleGraphical Abstract

    Triple Negative Breast Tumors Contain Heterogeneous Cancer Cells Expressing Distinct KRAS-Dependent Collective and Disseminative Invasion Programs

    Investigators cultured primary organoids from a basal-TNBC genetically engineered mouse model in 3D collagen gels to characterize their invasive behavior.
    [Oncogene]

    Abstract

    RAC1B Function Is Essential for Breast Cancer Stem Cell Maintenance and Chemoresistance of Breast Tumor Cells

    Researchers demonstrated that RAC1B, the only known alternatively spliced variant of the small GTPase RAC1, was expressed in a subset of breast CSCs (BCSCs) in vivo and its function was required for the maintenance of BCSCs and their chemoresistance to doxorubicin.
    [Oncogene]

    Full ArticlePress Release

    Histone Deacetylase Inhibitors Promote Breast Cancer Metastasis by Elevating NEDD9 Expression

    Scientists demonstrated that FAK inhibitors could reverse breast cancer metastasis induced by upregulation of NEDD9 via pan-histone deacetylase inhibitors, which might offer a potential combination therapy for breast cancer.
    [Signal Transduction and Targeted Therapy]

    Full Article

    Retarding Breast Tumor Growth with Nanoparticle-Facilitated Intravenous Delivery of BRCA1 and BRCA2 Tumor Suppressor Genes

    Investigators formulated inorganic carbonate apatite nanoparticles to carry and deliver the purified breast cancer type 1/2 (BRCA1/2) gene-bearing plasmid DNA both in vitro and in vivo.
    [Scientific Reports]

    Full Article
    Dr. Kristina McBurney and Leanna Bedell discuss how you can use social media to advance your scientific career. Watch now.
    REVIEWS

    The Impact of Tumor Microenvironment Secretome on Treg/IL-17–Producing Treg/Th17 Cells Axis in Breast Cancer: Molecular and Therapeutic Perspectives

    The authors discuss microRNAs, cytokines, extracellular vesicles, as well as transcription factors and immune checkpoints, that influence Treg/IL-17–producing Treg/Th17 cell axis in breast cancer.
    [Molecular Therapy Oncolytics]

    AbstractFull ArticleGraphical Abstract
    INDUSTRY AND POLICY NEWS

    Triple-Negative Breast Cancer: The RI-MUHC Enrolls First Patients in International Phase III Clinical Trial

    The Research Institute of the McGill University Health Centre (RI-MUHC) announced the initiation of a new randomized Phase III clinical trial, TROPION-Breast03, to test the efficacy of datopotamab deruxtecan with or without durvalumab as an adjuvant therapy for patients with Stage I-III TNBC.
    [McGill University Health Centre]

    Press Release

    Treadwell Therapeutics Announces Fast Track Designation Granted by the FDA to CFI-402257 for the Treatment of ER+/HER2 Breast Cancer

    Treadwell Therapeutics announced that the US FDA has granted Fast Track Designation to CFI-402257 for the treatment of adult patients with ER+/HER2 advanced breast cancer after disease progression on prior CDK4/6 inhibitors and endocrine therapy, both as a monotherapy and in combination with fulvestrant.
    [Treadwell Therapeutics]

    Press Release
    FEATURED EVENT

    ESMO Breast Cancer 2023

    May 11 – 13, 2023
    Berlin, Germany

    > See All Events

    JOB OPPORTUNITIES

    Group Leader – Cell Biology

    Pompeu Fabra University – Barcelona, Spain

    Research Scientist – Cancer Molecular Imaging

    Stanford Medicine – Stanford, California, United States

    Team Leader – Triple Negative Breast Cancer

    Toulouse Cancer Research Center – Toulouse, France

    PhD Positions – Life Sciences and Bioinformatics

    University Medical Center Freiburg – Freiburg, Germany

    Postdoctoral Scientist – Cancer Therapeutics

    UTHSC-Houston – Houston, Texas, United States

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Mammary Cell News Twitter